• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MAP 0.00% 18.0¢

MICROBA LIFE SCIENCES LIMITED

Microba Life Sciences Limited is an Australia-based precision microbiome company. The... Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for major chronic diseases and delivers gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Through its analysis and discovery platforms, it identifies microbiome-derived therapeutics and diagnostic tools to advance medicine. Through its Analysis Platform, it generates a global databank of microbiome samples and associated metadata to develop new health solutions. Its Discovery Platform enables partners to access this databank for the data-driven discovery of product opportunities. Its therapeutic platform is a repeatable platform for microbial therapeutic leads. It also offers a product portfolio of gastrointestinal, vaginal, oral, and urinary microbiome testing, together with a targeted set of evidence-based formulations. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MAP 23/04/24 3 1.1K
23/04/24 Last post  triage Comments Created with Sketch.  3  Views Created with Sketch.  1.1K 
MAP
News: MAP Microba Life Sciences Says A$4.00M In Q3 FY24 Unaudited Revenue
23/04/24 0 118
23/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  118 
MAP 23/04/24 0 182
23/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  182 
MAP 18/04/24 0 168
18/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  168 
MAP 16/04/24 0 174
16/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  174 
MAP 10/04/24 0 224
10/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  224 
MAP 10/04/24 0 144
10/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  144 
MAP 05/04/24 0 228
05/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  228 

See All Discussions arrow Created with Sketch.

Timeline

Q3 FY24 Quarterly Investor Presentation
23 Apr 09:08
 
Q3 FY24 Quarterly Activities Report & Appendix 4C
23 Apr 09:04
 
Details of Q3 FY24 Quarterly Report, Appendix 4C & Webinar
18 Apr 09:29
 
Microba Launches Investor Hub for Investor Engagement
16 Apr 09:08
 
Microba receives $6.08 million R&D Tax Incentive Refund
10 Apr 11:14
 
Notification of cessation of securities - MAP
10 Apr 10:59
 
View More arrow Created with Sketch.
(20min delay)
Last
18.0¢
Change
0.000(0.00%)
Mkt cap ! $80.61M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 50000 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 23868 2
View Market Depth
Last trade - 10.04am 09/05/2024 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.